Veterinary Medicines

Kefavet® vet. 500 mg, film-coated tablet

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Kefavet® vet. 500 mg, film-coated tablet
Kefavet vet 500 mg filmomhulde tabletten
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    526.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Blister, 28 tablets
  • Blister, 140 tablets
  • Blister, 70 tablets
  • Blister, 14 tablets
  • Blister, 30 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Orion Corporation
Marketing authorisation date:
Manufacturing sites for batch release:
  • Orion Corporation
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 106753
Date of authorisation status change:
Reference member state:
  • Sweden
Procedure number:
  • SE/V/0114/002
Concerned member states:
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Hungary
  • Iceland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 5/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."